Altogether, our data demonstrate that platelet-derived RANKL impairs NK cell antitumor reactivity with a less pronounced effect on cytotoxicity compared to production of IFNγ as second major effector mechanism by which NK cells contribute to tumor immunosurveillance. The gene discussed is TNFSF11; the disease is neoplasm.